カテゴリー： LP Information, 世界, 医療/バイオ

塞栓剤のグローバル市場予測2023-2029

◆英語タイトル：Global Embolic Agents Market Growth 2023-2029
	◆商品コード：LP23MY4655 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：104 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：医療機器＆消耗品

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「塞栓剤のグローバル市場」は、過去の販売実績から2022年の世界の塞栓剤の総販売量を検討し、2023年から2029年の予測される塞栓剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の塞栓剤の市場規模を掲載し、XXX百万米ドル規模の世界の塞栓剤市場の詳細な分析を提供します。本インサイトレポートは、世界の塞栓剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の塞栓剤市場における各社の独自のポジションをより深く理解するために、塞栓剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の塞栓剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。塞栓剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。塞栓剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。塞栓剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

塞栓剤の世界主要メーカーとしては、Medtronic、 Terumo、 Boston Scientific、 Merit Medical、 Johnson & Johnson、 GEM Italy、 IMBiotechnologies Ltd（IMB）、 Emboflu、 BTG、 Cook Medicalなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の塞栓剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では塞栓剤市場をセグメンテーションし、種類別 (液体塞栓剤、粒状塞栓剤、その他)、用途別 (潜出血、腫瘍治療、悪性高血圧、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：液体塞栓剤、粒状塞栓剤、その他

・用途別区分：潜出血、腫瘍治療、悪性高血圧、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の塞栓剤市場の10年間の市場状況・展望は？
・世界および地域別に見た塞栓剤市場成長の要因は何か？
・塞栓剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・塞栓剤のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：塞栓剤の年間販売量2018-2029、地域別現状・将来分析
・塞栓剤の種類別セグメント：液体塞栓剤、粒状塞栓剤、その他
・塞栓剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・塞栓剤の用途別セグメント：潜出血、腫瘍治療、悪性高血圧、その他
・塞栓剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の塞栓剤市場
・企業別のグローバル塞栓剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別の塞栓剤の年間売上：2018-2023年の売上、市場シェア
・企業別の塞栓剤販売価格
・主要企業の塞栓剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

塞栓剤の地域別レビュー
・地域別の塞栓剤市場規模2018-2023：年間販売量、売上
・主要国別の塞栓剤市場規模2018-2023：年間販売量、売上
・南北アメリカの塞栓剤販売の成長
・アジア太平洋の塞栓剤販売の成長
・ヨーロッパの塞栓剤販売の成長
・中東・アフリカの塞栓剤販売の成長

南北アメリカ市場
・南北アメリカの国別の塞栓剤販売量、売上（2018-2023）
・南北アメリカの塞栓剤の種類別販売量
・南北アメリカの塞栓剤の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の塞栓剤販売量、売上（2018-2023）
・アジア太平洋の塞栓剤の種類別販売量
・アジア太平洋の塞栓剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の塞栓剤販売量、売上（2018-2023）
・ヨーロッパの塞栓剤の種類別販売量
・ヨーロッパの塞栓剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の塞栓剤販売量、売上（2018-2023）
・中東・アフリカの塞栓剤の種類別販売量
・中東・アフリカの塞栓剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・塞栓剤の製造コスト構造分析
・塞栓剤の製造プロセス分析
・塞栓剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・塞栓剤の主要なグローバル販売業者
・塞栓剤の主要なグローバル顧客

地域別の塞栓剤市場予測レビュー
・地域別の塞栓剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・塞栓剤の種類別市場規模予測
・塞栓剤の用途別市場規模予測

主要企業分析
Medtronic、 Terumo、 Boston Scientific、 Merit Medical、 Johnson & Johnson、 GEM Italy、 IMBiotechnologies Ltd（IMB）、 Emboflu、 BTG、 Cook Medical
・企業情報
・塞栓剤製品
・塞栓剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Embolic Agent is a material used to block off blood flow through a vessel.
LPI (LP Information)’ newest research report, the “Embolic Agents Industry Forecast” looks at past sales and reviews total world Embolic Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Embolic Agents sales for 2023 through 2029. With Embolic Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Embolic Agents industry.
This Insight Report provides a comprehensive analysis of the global Embolic Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Embolic Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Embolic Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Embolic Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Embolic Agents.
The global Embolic Agents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Embolic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Embolic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Embolic Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Embolic Agents players cover Medtronic, Terumo, Boston Scientific, Merit Medical, Johnson & Johnson, GEM Italy, IMBiotechnologies Ltd（IMB）, Emboflu and BTG, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Embolic Agents market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Liquid Embolic Agents
Particulate Embolic Agents
Others
Segmentation by application
Occlude Bleeding
Oncotherapy
Malignant Hypertension
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Medtronic
Terumo
Boston Scientific
Merit Medical
Johnson & Johnson
GEM Italy
IMBiotechnologies Ltd（IMB）
Emboflu
BTG
Cook Medical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Embolic Agents market?
What factors are driving Embolic Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Embolic Agents market opportunities vary by end market size?
How does Embolic Agents break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Embolic Agents Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Embolic Agents by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Embolic Agents by Country/Region, 2018, 2022 & 2029
2.2 Embolic Agents Segment by Type
2.2.1 Liquid Embolic Agents
2.2.2 Particulate Embolic Agents
2.2.3 Others
2.3 Embolic Agents Sales by Type
2.3.1 Global Embolic Agents Sales Market Share by Type (2018-2023)
2.3.2 Global Embolic Agents Revenue and Market Share by Type (2018-2023)
2.3.3 Global Embolic Agents Sale Price by Type (2018-2023)
2.4 Embolic Agents Segment by Application
2.4.1 Occlude Bleeding
2.4.2 Oncotherapy
2.4.3 Malignant Hypertension
2.4.4 Others
2.5 Embolic Agents Sales by Application
2.5.1 Global Embolic Agents Sale Market Share by Application (2018-2023)
2.5.2 Global Embolic Agents Revenue and Market Share by Application (2018-2023)
2.5.3 Global Embolic Agents Sale Price by Application (2018-2023)
3 Global Embolic Agents by Company
3.1 Global Embolic Agents Breakdown Data by Company
3.1.1 Global Embolic Agents Annual Sales by Company (2018-2023)
3.1.2 Global Embolic Agents Sales Market Share by Company (2018-2023)
3.2 Global Embolic Agents Annual Revenue by Company (2018-2023)
3.2.1 Global Embolic Agents Revenue by Company (2018-2023)
3.2.2 Global Embolic Agents Revenue Market Share by Company (2018-2023)
3.3 Global Embolic Agents Sale Price by Company
3.4 Key Manufacturers Embolic Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Embolic Agents Product Location Distribution
3.4.2 Players Embolic Agents Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Embolic Agents by Geographic Region
4.1 World Historic Embolic Agents Market Size by Geographic Region (2018-2023)
4.1.1 Global Embolic Agents Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Embolic Agents Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Embolic Agents Market Size by Country/Region (2018-2023)
4.2.1 Global Embolic Agents Annual Sales by Country/Region (2018-2023)
4.2.2 Global Embolic Agents Annual Revenue by Country/Region (2018-2023)
4.3 Americas Embolic Agents Sales Growth
4.4 APAC Embolic Agents Sales Growth
4.5 Europe Embolic Agents Sales Growth
4.6 Middle East & Africa Embolic Agents Sales Growth
5 Americas
5.1 Americas Embolic Agents Sales by Country
5.1.1 Americas Embolic Agents Sales by Country (2018-2023)
5.1.2 Americas Embolic Agents Revenue by Country (2018-2023)
5.2 Americas Embolic Agents Sales by Type
5.3 Americas Embolic Agents Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Embolic Agents Sales by Region
6.1.1 APAC Embolic Agents Sales by Region (2018-2023)
6.1.2 APAC Embolic Agents Revenue by Region (2018-2023)
6.2 APAC Embolic Agents Sales by Type
6.3 APAC Embolic Agents Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Embolic Agents by Country
7.1.1 Europe Embolic Agents Sales by Country (2018-2023)
7.1.2 Europe Embolic Agents Revenue by Country (2018-2023)
7.2 Europe Embolic Agents Sales by Type
7.3 Europe Embolic Agents Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Embolic Agents by Country
8.1.1 Middle East & Africa Embolic Agents Sales by Country (2018-2023)
8.1.2 Middle East & Africa Embolic Agents Revenue by Country (2018-2023)
8.2 Middle East & Africa Embolic Agents Sales by Type
8.3 Middle East & Africa Embolic Agents Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Embolic Agents
10.3 Manufacturing Process Analysis of Embolic Agents
10.4 Industry Chain Structure of Embolic Agents
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Embolic Agents Distributors
11.3 Embolic Agents Customer
12 World Forecast Review for Embolic Agents by Geographic Region
12.1 Global Embolic Agents Market Size Forecast by Region
12.1.1 Global Embolic Agents Forecast by Region (2024-2029)
12.1.2 Global Embolic Agents Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Embolic Agents Forecast by Type
12.7 Global Embolic Agents Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Embolic Agents Product Portfolios and Specifications
13.1.3 Medtronic Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Terumo
13.2.1 Terumo Company Information
13.2.2 Terumo Embolic Agents Product Portfolios and Specifications
13.2.3 Terumo Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Terumo Main Business Overview
13.2.5 Terumo Latest Developments
13.3 Boston Scientific
13.3.1 Boston Scientific Company Information
13.3.2 Boston Scientific Embolic Agents Product Portfolios and Specifications
13.3.3 Boston Scientific Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boston Scientific Main Business Overview
13.3.5 Boston Scientific Latest Developments
13.4 Merit Medical
13.4.1 Merit Medical Company Information
13.4.2 Merit Medical Embolic Agents Product Portfolios and Specifications
13.4.3 Merit Medical Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merit Medical Main Business Overview
13.4.5 Merit Medical Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Embolic Agents Product Portfolios and Specifications
13.5.3 Johnson & Johnson Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 GEM Italy
13.6.1 GEM Italy Company Information
13.6.2 GEM Italy Embolic Agents Product Portfolios and Specifications
13.6.3 GEM Italy Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 GEM Italy Main Business Overview
13.6.5 GEM Italy Latest Developments
13.7 IMBiotechnologies Ltd（IMB）
13.7.1 IMBiotechnologies Ltd（IMB） Company Information
13.7.2 IMBiotechnologies Ltd（IMB） Embolic Agents Product Portfolios and Specifications
13.7.3 IMBiotechnologies Ltd（IMB） Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IMBiotechnologies Ltd（IMB） Main Business Overview
13.7.5 IMBiotechnologies Ltd（IMB） Latest Developments
13.8 Emboflu
13.8.1 Emboflu Company Information
13.8.2 Emboflu Embolic Agents Product Portfolios and Specifications
13.8.3 Emboflu Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Emboflu Main Business Overview
13.8.5 Emboflu Latest Developments
13.9 BTG
13.9.1 BTG Company Information
13.9.2 BTG Embolic Agents Product Portfolios and Specifications
13.9.3 BTG Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BTG Main Business Overview
13.9.5 BTG Latest Developments
13.10 Cook Medical
13.10.1 Cook Medical Company Information
13.10.2 Cook Medical Embolic Agents Product Portfolios and Specifications
13.10.3 Cook Medical Embolic Agents Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cook Medical Main Business Overview
13.10.5 Cook Medical Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Embolic Agents Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Embolic Agents Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Liquid Embolic Agents
Table 4. Major Players of Particulate Embolic Agents
Table 5. Major Players of Others
Table 6. Global Embolic Agents Sales by Type (2018-2023) & (K Units)
Table 7. Global Embolic Agents Sales Market Share by Type (2018-2023)
Table 8. Global Embolic Agents Revenue by Type (2018-2023) & ($ million)
Table 9. Global Embolic Agents Revenue Market Share by Type (2018-2023)
Table 10. Global Embolic Agents Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Embolic Agents Sales by Application (2018-2023) & (K Units)
Table 12. Global Embolic Agents Sales Market Share by Application (2018-2023)
Table 13. Global Embolic Agents Revenue by Application (2018-2023)
Table 14. Global Embolic Agents Revenue Market Share by Application (2018-2023)
Table 15. Global Embolic Agents Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Embolic Agents Sales by Company (2018-2023) & (K Units)
Table 17. Global Embolic Agents Sales Market Share by Company (2018-2023)
Table 18. Global Embolic Agents Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Embolic Agents Revenue Market Share by Company (2018-2023)
Table 20. Global Embolic Agents Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Embolic Agents Producing Area Distribution and Sales Area
Table 22. Players Embolic Agents Products Offered
Table 23. Embolic Agents Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Embolic Agents Sales by Geographic Region (2018-2023) & (K Units)
Table 27. Global Embolic Agents Sales Market Share Geographic Region (2018-2023)
Table 28. Global Embolic Agents Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Embolic Agents Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Embolic Agents Sales by Country/Region (2018-2023) & (K Units)
Table 31. Global Embolic Agents Sales Market Share by Country/Region (2018-2023)
Table 32. Global Embolic Agents Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Embolic Agents Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Embolic Agents Sales by Country (2018-2023) & (K Units)
Table 35. Americas Embolic Agents Sales Market Share by Country (2018-2023)
Table 36. Americas Embolic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Embolic Agents Revenue Market Share by Country (2018-2023)
Table 38. Americas Embolic Agents Sales by Type (2018-2023) & (K Units)
Table 39. Americas Embolic Agents Sales by Application (2018-2023) & (K Units)
Table 40. APAC Embolic Agents Sales by Region (2018-2023) & (K Units)
Table 41. APAC Embolic Agents Sales Market Share by Region (2018-2023)
Table 42. APAC Embolic Agents Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Embolic Agents Revenue Market Share by Region (2018-2023)
Table 44. APAC Embolic Agents Sales by Type (2018-2023) & (K Units)
Table 45. APAC Embolic Agents Sales by Application (2018-2023) & (K Units)
Table 46. Europe Embolic Agents Sales by Country (2018-2023) & (K Units)
Table 47. Europe Embolic Agents Sales Market Share by Country (2018-2023)
Table 48. Europe Embolic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Embolic Agents Revenue Market Share by Country (2018-2023)
Table 50. Europe Embolic Agents Sales by Type (2018-2023) & (K Units)
Table 51. Europe Embolic Agents Sales by Application (2018-2023) & (K Units)
Table 52. Middle East & Africa Embolic Agents Sales by Country (2018-2023) & (K Units)
Table 53. Middle East & Africa Embolic Agents Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Embolic Agents Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Embolic Agents Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Embolic Agents Sales by Type (2018-2023) & (K Units)
Table 57. Middle East & Africa Embolic Agents Sales by Application (2018-2023) & (K Units)
Table 58. Key Market Drivers & Growth Opportunities of Embolic Agents
Table 59. Key Market Challenges & Risks of Embolic Agents
Table 60. Key Industry Trends of Embolic Agents
Table 61. Embolic Agents Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Embolic Agents Distributors List
Table 64. Embolic Agents Customer List
Table 65. Global Embolic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 66. Global Embolic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Embolic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 68. Americas Embolic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Embolic Agents Sales Forecast by Region (2024-2029) & (K Units)
Table 70. APAC Embolic Agents Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Embolic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 72. Europe Embolic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Embolic Agents Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Middle East & Africa Embolic Agents Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Embolic Agents Sales Forecast by Type (2024-2029) & (K Units)
Table 76. Global Embolic Agents Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Embolic Agents Sales Forecast by Application (2024-2029) & (K Units)
Table 78. Global Embolic Agents Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Medtronic Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 80. Medtronic Embolic Agents Product Portfolios and Specifications
Table 81. Medtronic Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Medtronic Main Business
Table 83. Medtronic Latest Developments
Table 84. Terumo Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 85. Terumo Embolic Agents Product Portfolios and Specifications
Table 86. Terumo Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Terumo Main Business
Table 88. Terumo Latest Developments
Table 89. Boston Scientific Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 90. Boston Scientific Embolic Agents Product Portfolios and Specifications
Table 91. Boston Scientific Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Boston Scientific Main Business
Table 93. Boston Scientific Latest Developments
Table 94. Merit Medical Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 95. Merit Medical Embolic Agents Product Portfolios and Specifications
Table 96. Merit Medical Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Merit Medical Main Business
Table 98. Merit Medical Latest Developments
Table 99. Johnson & Johnson Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 100. Johnson & Johnson Embolic Agents Product Portfolios and Specifications
Table 101. Johnson & Johnson Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Johnson & Johnson Main Business
Table 103. Johnson & Johnson Latest Developments
Table 104. GEM Italy Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 105. GEM Italy Embolic Agents Product Portfolios and Specifications
Table 106. GEM Italy Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. GEM Italy Main Business
Table 108. GEM Italy Latest Developments
Table 109. IMBiotechnologies Ltd（IMB） Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 110. IMBiotechnologies Ltd（IMB） Embolic Agents Product Portfolios and Specifications
Table 111. IMBiotechnologies Ltd（IMB） Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 112. IMBiotechnologies Ltd（IMB） Main Business
Table 113. IMBiotechnologies Ltd（IMB） Latest Developments
Table 114. Emboflu Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 115. Emboflu Embolic Agents Product Portfolios and Specifications
Table 116. Emboflu Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 117. Emboflu Main Business
Table 118. Emboflu Latest Developments
Table 119. BTG Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 120. BTG Embolic Agents Product Portfolios and Specifications
Table 121. BTG Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 122. BTG Main Business
Table 123. BTG Latest Developments
Table 124. Cook Medical Basic Information, Embolic Agents Manufacturing Base, Sales Area and Its Competitors
Table 125. Cook Medical Embolic Agents Product Portfolios and Specifications
Table 126. Cook Medical Embolic Agents Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 127. Cook Medical Main Business
Table 128. Cook Medical Latest Developments
List of Figures
Figure 1. Picture of Embolic Agents
Figure 2. Embolic Agents Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Embolic Agents Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Embolic Agents Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Embolic Agents Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Liquid Embolic Agents
Figure 10. Product Picture of Particulate Embolic Agents
Figure 11. Product Picture of Others
Figure 12. Global Embolic Agents Sales Market Share by Type in 2022
Figure 13. Global Embolic Agents Revenue Market Share by Type (2018-2023)
Figure 14. Embolic Agents Consumed in Occlude Bleeding
Figure 15. Global Embolic Agents Market: Occlude Bleeding (2018-2023) & (K Units)
Figure 16. Embolic Agents Consumed in Oncotherapy
Figure 17. Global Embolic Agents Market: Oncotherapy (2018-2023) & (K Units)
Figure 18. Embolic Agents Consumed in Malignant Hypertension
Figure 19. Global Embolic Agents Market: Malignant Hypertension (2018-2023) & (K Units)
Figure 20. Embolic Agents Consumed in Others
Figure 21. Global Embolic Agents Market: Others (2018-2023) & (K Units)
Figure 22. Global Embolic Agents Sales Market Share by Application (2022)
Figure 23. Global Embolic Agents Revenue Market Share by Application in 2022
Figure 24. Embolic Agents Sales Market by Company in 2022 (K Units)
Figure 25. Global Embolic Agents Sales Market Share by Company in 2022
Figure 26. Embolic Agents Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Embolic Agents Revenue Market Share by Company in 2022
Figure 28. Global Embolic Agents Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Embolic Agents Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Embolic Agents Sales 2018-2023 (K Units)
Figure 31. Americas Embolic Agents Revenue 2018-2023 ($ Millions)
Figure 32. APAC Embolic Agents Sales 2018-2023 (K Units)
Figure 33. APAC Embolic Agents Revenue 2018-2023 ($ Millions)
Figure 34. Europe Embolic Agents Sales 2018-2023 (K Units)
Figure 35. Europe Embolic Agents Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Embolic Agents Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Embolic Agents Revenue 2018-2023 ($ Millions)
Figure 38. Americas Embolic Agents Sales Market Share by Country in 2022
Figure 39. Americas Embolic Agents Revenue Market Share by Country in 2022
Figure 40. Americas Embolic Agents Sales Market Share by Type (2018-2023)
Figure 41. Americas Embolic Agents Sales Market Share by Application (2018-2023)
Figure 42. United States Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Embolic Agents Sales Market Share by Region in 2022
Figure 47. APAC Embolic Agents Revenue Market Share by Regions in 2022
Figure 48. APAC Embolic Agents Sales Market Share by Type (2018-2023)
Figure 49. APAC Embolic Agents Sales Market Share by Application (2018-2023)
Figure 50. China Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Embolic Agents Sales Market Share by Country in 2022
Figure 58. Europe Embolic Agents Revenue Market Share by Country in 2022
Figure 59. Europe Embolic Agents Sales Market Share by Type (2018-2023)
Figure 60. Europe Embolic Agents Sales Market Share by Application (2018-2023)
Figure 61. Germany Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Embolic Agents Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Embolic Agents Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Embolic Agents Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Embolic Agents Sales Market Share by Application (2018-2023)
Figure 70. Egypt Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Embolic Agents Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Embolic Agents in 2022
Figure 76. Manufacturing Process Analysis of Embolic Agents
Figure 77. Industry Chain Structure of Embolic Agents
Figure 78. Channels of Distribution
Figure 79. Global Embolic Agents Sales Market Forecast by Region (2024-2029)
Figure 80. Global Embolic Agents Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Embolic Agents Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Embolic Agents Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Embolic Agents Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Embolic Agents Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 塞栓剤のグローバル市場予測2023-2029(Global Embolic Agents Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

塞栓剤のグローバル市場予測2023-2029

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp